![Image for Neuropsychotropic drug therapy course.](https://learning.nursing.uw.edu/wp-content/uploads/2022/05/neuropsych19-braintree-600px.png)
Neuropsychotropic Drug Therapy 2019 | All Modules
On-Demand Program
Course Description
This on-demand lecture series is designed as a neuropsychotropic pharmacology update at the advanced practice level. Sessions focus on current recommendations and controversies in drug therapy for common neuropsychiatric health concerns. Teaching methods include video, PDF handout and case analysis.
Target Audience
For psychiatric nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
- Compare forms of medication assisted treatment (MAT) for opioid use disorder (OUD).
- Recognize the diagnostic criteria for eating disorders, including: anorexia nervosa, bulimia nervosa, binge-eating disorder, and avoidant restrictive food intake disorder.
- Apply basic understanding of drug-induced movement disorders.
- Recognize migraines quickly in clinic.
- Describe ketamine pharmacology.
Featured Topics
To register for just one or a few modules, click on the topic:
- Psychological Trauma, PTDS and Pain – Stephen Hunt, MD
- Eating Disorders: The Role of Psychopharmacology – Sarah Golub, MD, MPH
- Drug-Induced Movement Disorders – Kimmy Su, MD
- CGRP Agents for Migraine Prevention – Donald Bright, MD
- Ketamine Assisted Psychotherapy for Psychiatric Disorders – Nathaniel Schmidt, DNP, ARNP, PMHNP-BC
![Image for Neuropsychotropic drug therapy course.](https://learning.nursing.uw.edu/wp-content/uploads/2022/05/neuropsych19-braintree-600px.png)
Neuropsychotropic Drug Therapy 2019
CGRP Agents for Migraine Prevention
On-Demand Program
Speaker
Donald Bright, MD
Staff Neurologist, VA Puget Sound Health Care System, Seattle, WA
Target Audience
For psychiatric nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Recognize migraine quickly in clinic.
- Discuss the overview of traditional acute and prophylactic treatments.
- Describe CGRP and its role in migraine and as a target for prophylaxis.
![Image for Neuropsychotropic drug therapy course.](https://learning.nursing.uw.edu/wp-content/uploads/2022/05/neuropsych19-braintree-600px.png)
Neuropsychotropic Drug Therapy 2019
Drug-Induced Movement Disorders
On-Demand Program
Speaker
Kimmy Su, MD
Fellow, Movement Disorders, VA Puget Sound Health Care System, Seattle, WA
Target Audience
For psychiatric nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Know the basic understanding of drug-induced movement disorders.
- Describe the general approach to workup and management of tremors.
- Discuss the general approach to management of tardive dyskinesia.
![Image for Neuropsychotropic drug therapy course.](https://learning.nursing.uw.edu/wp-content/uploads/2022/05/neuropsych19-braintree-600px.png)
Neuropsychotropic Drug Therapy 2019
Eating Disorders: The Role of Psychopharmacology
On-Demand Program
Speaker
Sarah Golub, MD, MPH
Divisional of Adolescent Medicine, Seattle Children’s Hospital, Seattle, WA
Target Audience
For psychiatric nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Recognize the diagnostic criteria for eating disorders, including anorexia nervosa, bulimia nervosa, binge-eating disorder and avoidant restrictive food intake disorder.
- Appreciate the clinical approach to managing eating disorders.
- Discuss the role of psychiatric medications in the management of eating disorders.
![Image for Neuropsychotropic drug therapy course.](https://learning.nursing.uw.edu/wp-content/uploads/2022/05/neuropsych19-braintree-600px.png)
Neuropsychotropic Drug Therapy 2019
Ketamine Assisted Psychotherapy
On-Demand Program
Speaker
Nathaniel Schmidt, DNP, ARNP, PMHNP-BC
Nurse Practitioner, Private Practice, Advanced Integrative Medical Science Institute, Seattle, WA
Target Audience
For psychiatric nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Discuss Ketamine pharmacology.
- Describe Ketamine uses combined with therapy to treat various conditions.
- Understand dosage, routes of administration, side effects and contraindications.
![Banner for Neuropsychotropic Drug Therapy course.](https://learning.nursing.uw.edu/wp-content/uploads/2021/07/neuropsych2019-banner-600x300-1.png)
Neuropsychotropic Drug Therapy 2019
Psychological Trauma, PTSD and Pain: The Role and Risk of Medications
On-Demand Program
Speaker
Stephen Hunt, MD
Director, Deployment Health Clinic, VAPSHCS, Seattle, WA
Target Audience
For psychiatric nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Describe the role and optimize the use of medications in PTSD treatment in your setting.
- Integrate pharmacological and non-pharmacological approaches to PTSD treatment in your clinical setting.
- Recognize and respond to the full spectrum of trauma residuals in individuals you are addressing and treating in your clinical setting.
![Image for Neuropsychotropic drug therapy course.](https://learning.nursing.uw.edu/wp-content/uploads/2022/05/neuropscyh2020-braintree-600px.png)
Neuropsychotropic Drug Therapy 2020 | All Modules
On-Demand Program
Description
This on-demand lecture series is designed as a neuropsychotropic pharmacology update at the advanced practice level. Sessions focus on current recommendations and controversies regarding drug therapy for common neuropsychiatric health issues and include appropriate pharmacotherapeutic principles and recommendations for patient and family education. Teaching methods include lecture, discussion and case analysis.
Target Audience
For psychiatric nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
Upon completion of this conference, participants will be better able to:
- Describe the role and optimize the use of medications in PTSD treatment in your setting.
- Recognize the diagnostic criteria for eating disorders, including: anorexia nervosa, bulimia nervosa, binge-eating disorder, and avoidant restrictive food intake disorder.
- Apply basic understanding of drug-induced movement disorders.
- Recognize migraines quickly in clinic.
- Discuss ketamine pharmacology.
Featured Topics
- Telepsychiatry: Glamour and Glitch? – Bhinna Park
- Trauma, PTSD, and Psychopharmacology – April Gerlock
- Prescribing and Deprescribing Medications in Adolescents – Kathy Kroening
- Update on Long Acting Antipsychotic Injectables – Chelsea Markle
- Is it All in Your Head? How We are Using Psychiatric Meds in Headache – Kate Kennedy
- Esketamine: An Introduction – Matthew Schreiber
Speakers
- April Gerlock, PhD, PMHNP-BC, ARNP, Clinical Professor, UW School of Nursing
- Kate Kennedy, ARNP-BC, CAQ in Headache Medicine, Neurology Nurse Practitioner, Overlake Neuroscience Institute, Bellevue
- Kathy Kroening, PhD, ARNP, Nurse Practitioner, Kaiser Permanente; Senior Lecturer, UW School of Nursing
- Chelsea Markle, PharmD, BCPP, Clinical Pharmacist, UW Medicine/Harborview Psychiatry
- Bhinna Park, MD, MA, Psychiatrist, Department of Corrections, WA State, Gig Harbor
- Matthew Schreiber, MD, PhD, Staff Psychiatrist, VA Puget Sound HCS, Seattle; Assistant Professor, UW Department of Psychiatry and Behavioral Sciences
![Image for Neuropsychotropic drug therapy course.](https://learning.nursing.uw.edu/wp-content/uploads/2022/05/neuropscyh2020-braintree-600px.png)
Neuropsychotropic Drug Therapy 2020
When Psychiatry Breaks Skin: An Update on Long Acting Injectable Antipsychotics
On-Demand Program
Speaker
Chelsea Markle, PharmD, BCPP, Clinical Pharmacist, UW Medicine/Harborview Psychiatry
Target Audience
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Discuss history and utility of long acting injectable antipsychotics.
- Review pharmacokinetic considerations with regard to long acting injectable antipsychotics.
- Discuss practical application of each long acting injection.
![Image for Neuropsychotropic drug therapy course.](https://learning.nursing.uw.edu/wp-content/uploads/2022/05/neuropscyh2020-braintree-600px.png)
Neuropsychotropic Drug Therapy 2020
Esketamine: An Introduction
On-Demand Program
Speaker
Matthew Schreiber, MD, PhD
Staff Psychiatrist, VA Puget Sound HCS, Seattle; Assistant Professor, UW Department of Psychiatry and Behavioral Sciences
Target Audience
Advanced practice nurse practitioners, especially psychiatric and family nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Gain knowledge about the clinical research data on esketamine.
- Appreciate the potential clinical uses and benefits of esketamine.
- Use esketamine as a learning example of the drug development.
![Image for Neuropsychotropic drug therapy course.](https://learning.nursing.uw.edu/wp-content/uploads/2022/05/neuropscyh2020-braintree-600px.png)
Neuropsychotropic Drug Therapy 2020
Is it All in Your Head? How We are Using Psychiatric Meds in Headache
On-Demand Program
Speaker
Kate Kennedy, ARNP-BC, CAQ in Headache Medicine
Neurology Nurse Practitioner, Overlake Neuroscience Institute, Bellevue
Target Audience
For psychiatric nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Name 3 psychotropic medications used in headache.
- Describe how to select these medications for certain types of headache in patients with selected psychiatric conditions.
- Describe how transcranial magnetic stimulation is used in psychiatry as well as in migraines.
![Image for Neuropsychotropic drug therapy course.](https://learning.nursing.uw.edu/wp-content/uploads/2022/05/neuropscyh2020-braintree-600px.png)
Neuropsychotropic Drug Therapy 2020
Prescribing and Deprescribing Medications in Adolescents
On-Demand Program
Speaker
Kathy Kroening, PhD, ARNP
Nurse Practitioner, Kaiser Permanente; Senior Lecturer, UW School of Nursing
Target Audience
Advanced practice nurse practitioners, especially psychiatric and family nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Discuss adolescent behaviors that create symptoms commonly seen in depression, anxiety, and psychosis.
- Discuss five medication safety tips for use in teens.
- Discuss three strategies for tapering teens off medications.
![Image for Neuropsychotropic drug therapy course.](https://learning.nursing.uw.edu/wp-content/uploads/2022/05/neuropscyh2020-braintree-600px.png)
Neuropsychotropic Drug Therapy 2020
Telepsychiatry: Glamour and Glitch?
On-Demand Program
Speaker
Bhinna Park, MD, MA, Psychiatrist, Department of Corrections, WA State, Gig Harbor
Target Audience
Advanced practice nurse practitioners, especially psychiatric and family nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Provide useful tips and tricks for telepsychiatry.
- Learn to build rapport with telepsychiatry patients.
- Explain psychopharmacology and its limitations within the correctional system (i.e. available formulary, abuse potential, etc).